Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Garg

Showing results (251-260 of 352) with videos related to

Pageof 36
Sort By:
Dermatology and Therapy|January 6, 2024
Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported OutcomesAlexa B Kimball, Joslyn Kirby, John R Ingram, et al.
ACS Pharmacology & Translational Science|February 17, 2023
Protective Effects of Rifampicin and Its Analog Rifampicin Quinone in a Mouse Model of Obesity-Induced Type 2 DiabetesAmit Garg, Maroof Alam, Shakuntala Bai, et al.
Dermatology (Basel, Switzerland)|August 20, 2018
Are Your Patients Satisfied A Systematic Review of Treatment Satisfaction Measures in PsoriasisNicole Salame, Lourdes M Perez-Chada, Sanminder Singh, et al.
Dermatology (Basel, Switzerland)|June 29, 2023
Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey StudyRahul Masson, Terri Shih, Sarah Park, et al.
Journal of Clinical Pharmacology|April 27, 2010
Effect of diltiazem, a moderate CYP3A inhibitor, on the pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein inhibitor, in healthy subjectsAmit Garg, Andrea Maes, Christy Corr, et al.
Journal of the American Academy of Dermatology|December 10, 2014
The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatologyAlice B Gottlieb, Adriane A Levin, April W Armstrong, et al.
Archives of Dermatological Research|September 1, 2018
Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiativeLourdes Maria Perez-Chada, Jeffrey M Cohen, Alice Bendix Gottlieb, et al.
Cancer Chemotherapy and Pharmacology|January 12, 2017
Pharmacokinetic and exposure-response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+ early breast cancerAngelica L Quartino, Hanbin Li, Jin Y Jin, et al.
JAMA Dermatology|April 26, 2023
Validation of the Hidradenitis Suppurativa Investigator Global Assessment: A Novel Hidradenitis Suppurativa-Specific Investigator Global Assessment for Use in Interventional TrialsAmit Garg, Carla Zema, Valerie Ciaravino, et al.
Dermatology (Basel, Switzerland)|January 29, 2020
Examination of Treatment Satisfaction Instruments in Psoriasis: 2017 Results from the Psoriasis Working Group of the International Dermatology Outcome Measures (IDEOM)Heather Kornmehl, Kristina Callis Duffin, Nicole Salame, et al.
Pageof 36

Showing results (251-260 of 352) with videos related to

Sort By:
Pageof 36
Dermatology and Therapy|January 6, 2024
Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported OutcomesAlexa B Kimball, Joslyn Kirby, John R Ingram, et al.
ACS Pharmacology & Translational Science|February 17, 2023
Protective Effects of Rifampicin and Its Analog Rifampicin Quinone in a Mouse Model of Obesity-Induced Type 2 DiabetesAmit Garg, Maroof Alam, Shakuntala Bai, et al.
Dermatology (Basel, Switzerland)|August 20, 2018
Are Your Patients Satisfied A Systematic Review of Treatment Satisfaction Measures in PsoriasisNicole Salame, Lourdes M Perez-Chada, Sanminder Singh, et al.
Dermatology (Basel, Switzerland)|June 29, 2023
Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey StudyRahul Masson, Terri Shih, Sarah Park, et al.
Journal of Clinical Pharmacology|April 27, 2010
Effect of diltiazem, a moderate CYP3A inhibitor, on the pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein inhibitor, in healthy subjectsAmit Garg, Andrea Maes, Christy Corr, et al.
Journal of the American Academy of Dermatology|December 10, 2014
The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatologyAlice B Gottlieb, Adriane A Levin, April W Armstrong, et al.
Archives of Dermatological Research|September 1, 2018
Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiativeLourdes Maria Perez-Chada, Jeffrey M Cohen, Alice Bendix Gottlieb, et al.
Cancer Chemotherapy and Pharmacology|January 12, 2017
Pharmacokinetic and exposure-response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+ early breast cancerAngelica L Quartino, Hanbin Li, Jin Y Jin, et al.
JAMA Dermatology|April 26, 2023
Validation of the Hidradenitis Suppurativa Investigator Global Assessment: A Novel Hidradenitis Suppurativa-Specific Investigator Global Assessment for Use in Interventional TrialsAmit Garg, Carla Zema, Valerie Ciaravino, et al.
Dermatology (Basel, Switzerland)|January 29, 2020
Examination of Treatment Satisfaction Instruments in Psoriasis: 2017 Results from the Psoriasis Working Group of the International Dermatology Outcome Measures (IDEOM)Heather Kornmehl, Kristina Callis Duffin, Nicole Salame, et al.
Pageof 36